SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-17-262345
Filing Date
2017-08-18
Accepted
2017-08-18 17:18:40
Documents
7
Effectiveness Date
2017-08-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT PERTAINING TO A MERGER d391632ddefm14a.htm DEFM14A 1481841
2 GRAPHIC g391632g09u11.jpg GRAPHIC 20504
3 GRAPHIC g391632g10g71.jpg GRAPHIC 26624
4 GRAPHIC g391632g43f80.jpg GRAPHIC 29142
5 GRAPHIC g391632g99t54.jpg GRAPHIC 37398
6 GRAPHIC g391632page17.jpg GRAPHIC 209618
7 GRAPHIC g391632page18.jpg GRAPHIC 179761
  Complete submission text file 0001193125-17-262345.txt   2176259
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 000-19825 | Film No.: 171041711
SIC: 2834 Pharmaceutical Preparations